Drug Development Press Releases

Drug discovery is a brutal machine—a high-stakes relay from biological chaos to therapeutic hope.

Neurolixis issued a new US patent for treatment of Fragile X syndrome with NLX-101

IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on developing innovative ophthalmic therapeutics, organized a panel of dry eye experts and clinicians to gain key insights on dry eye treatment innovations.